<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Batchelor Ernstsen | Activity</title>
	<link>https://recash.wpsoul.net/members/birthsmash89/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/birthsmash89/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Batchelor Ernstsen.</description>
	<lastBuildDate>Mon, 27 Jul 2026 23:34:59 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0f5c8a00f8691e289a6f5ca13dc7794a</guid>
				<title>Batchelor Ernstsen posted an update: ) and pathway analyses. The pathway analyses shows that [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/133317/</link>
				<pubDate>Wed, 01 Jan 2025 08:16:00 +0000</pubDate>

									<content:encoded><![CDATA[<p>) and pathway analyses. The pathway analyses shows that teriflunomide significantly inhibited cell proliferation and promoted cell apoptosis partly by participating in Wnt signaling pathways. These findings suggest that teriflunomide could be a potential drug for chemotherapy and molecularly targeted therapies of HCC.Understanding older adults&hellip;<span class="activity-read-more" id="activity-read-more-133317"><a href="https://recash.wpsoul.net/activity/p/133317/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">709420a31320092bc841b1d25b685156</guid>
				<title>Batchelor Ernstsen became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/97253/</link>
				<pubDate>Fri, 20 Dec 2024 23:00:56 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>